Article info

Download PDFPDF
Extended report
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)

Authors

  1. Correspondence to Professor Jean-Yves Reginster, Department of Public Health, Epidemiology and Health Economics, Liège State University, Liège, Belgium, Quartier Hôpital – CHU B23, venue Hippocrate, 13, 4000 Liège, Belgium; jyr.ch{at}bluewin.ch
View Full Text

Citation

Reginster J, Dudler J, Blicharski T, et al
Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)

Publication history

  • Received November 22, 2016
  • Revised March 15, 2017
  • Accepted March 20, 2017
  • First published May 22, 2017.
Online issue publication 
August 10, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.